AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15848518
Drug: Mixed chimerism
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed chimerism protocol with thymic transplantation of donor renal tissue, two donor-specific transfusions, low-intensity conditioning, and high-dose HSCT before renal transplantation.
Trial: 6119042
Drug: Intranasal budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal budesonide 400 microgram per day
Trial: 6119042
Drug: Intranasal budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal budesonide 200 microgram per day
Trial: 6119042
Drug: Intranasal budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal budesonide (both dosages)
Trial: 22614886
Drug: Deferred antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred antiretroviral therapy (ART)
Trial: 24165392
Drug: ADM-facilitated one-stage
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADM-facilitated one-stage implant reconstruction
Trial: 24165392
Drug: Two-stage tissue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-stage tissue expander/implant (TE/I) reconstruction
Trial: 17005549
Drug: Azithromycin 1.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 1.5% eye drops twice daily for 2 days
Trial: 17005549
Drug: Azithromycin 1.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 1.5% eye drops twice daily for 3 days
Trial: 17005549
Drug: Azithromycin single
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin single 20 mg/kg oral dose
Trial: 17005549
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (eye drops and oral)
Trial: 15089820
Drug: Intravenous tyramine
RxNorm normalized name: tyramine
DrugBank: Tyramine (DB08841)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tyramine injections
Trial: 11001599
Drug: Cholinesterase inhibitor
RxNorm normalized name: Acetylcholinesterase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitor therapy (donepezil)
Trial: 9104896
Drug: Aspirin treatment
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin treatment at hospital admission
Trial: 9104896
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists treatment at hospital admission
Trial: 9104896
Drug: Beta blockers
RxNorm normalized name: BETA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blockers treatment at hospital admission
Trial: 9104896
Drug: Combination anti-ischemic
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination anti-ischemic therapy at hospital admission
Trial: 9104896
Drug: Nitrates treatment
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrates treatment at discharge
Trial: 9104896
Drug: Combination anti-ischemic
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination anti-ischemic therapy at discharge
Trial: 9104896
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitors treatment
Trial: 9104896
Drug: Lipid-lowering agents
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-lowering agents treatment
Trial: 27067394
Drug: Sonidegib 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sonidegib 800 mg
Trial: 24814043
Drug: Two 4-hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two 4-hour interactive training sessions for nursing staff on appropriate medication treatment
Trial: 15723732
Drug: Active 4-mg
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active 4-mg nicotine lozenge
Trial: 15723732
Drug: Placebo (patch)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (patch)
Trial: 15723732
Drug: Placebo (lozenge)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lozenge)
Trial: 16025971
Drug: Combined internal-external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined internal-external therapy of TCM (internal administering of Chinese recipe and external applying of Fuxiong plaster)
Trial: 16025971
Drug: Combined internal-external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined internal-external therapy of TCM
Trial: 12844132
Drug: Fluconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (200 mg daily, 400 mg on day 1)
Trial: 11111141
Drug: N(G)‐monomethyl‐L‐arginine (LNMMA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N(G)‐monomethyl‐L‐arginine (LNMMA) infused intracoronarily at 4, 8 and 16 micromol/min
Trial: 11111141
Drug: N(G)‐monomethyl‐L‐arginine (LNMMA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N(G)‐monomethyl‐L‐arginine (LNMMA) infused intracoronarily
Trial: 8806006
Drug: Intranasal salmon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal salmon calcitonin (50 IU per dose)
Trial: 1282615
Drug: Nisoldipine at
RxNorm normalized name: Nisoldipine
DrugBank: Nisoldipine (DB00401)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nisoldipine at a dose of 20 mg daily for 4 weeks
Trial: 1282615
Drug: Beta-acetyldigoxin at
RxNorm normalized name: acetyldigoxins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-acetyldigoxin at a dose of 0.3 mg daily for 4 weeks
Trial: 29138241
Drug: GH (2
RxNorm normalized name: Somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GH (2 mg/day)
Trial: 29138241
Drug: Combined GH
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined GH (2 mg/day) and testosterone (250 mg/week)
Trial: 29138241
Drug: Testosterone (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (250 mg/week)
Trial: 27079660
Drug: Acetyl-L-carnitine (ALCAR)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALCAR) 3,000 mg/day orally for 2 months
Trial: 24394686
Drug: Xylitol syrup
RxNorm normalized name: Xylitol
DrugBank: Xylitol (DB11195)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Xylitol syrup (5 g, 3 times per day)
Trial: 19616743
Drug: High-dose radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radiotherapy (HDRT)
Trial: 19616743
Drug: Conventional-dose radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional-dose radiotherapy (CDRT)
Trial: 8719263
Drug: Metoprolol (0.29
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (0.29 mg kg‐1)
Trial: 8719263
Drug: Propranolol (0.28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.28 mg kg‐1)
Trial: 773081
Drug: Inderal 40
RxNorm normalized name: Inderal 40mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inderal 40 mg q.i.d.
Trial: 773081
Drug: d-propranolol 40
RxNorm normalized name: propranolol hydrochloride 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-propranolol 40 mg q.i.d.
Trial: 28224720
Drug: Pyridostigmine bromide
RxNorm normalized name: Pyridostigmine Bromide
DrugBank: Pyridostigmine (DB00545)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pyridostigmine bromide (3 × 60 mg/day for 14 days)
Trial: 28224720
Drug: Fludrocortisone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone (1 × 0.2 mg/day for 14 days)
Trial: 22782640
Drug: Golimumab with
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Golimumab with isoniazid for latent TB treatment
Trial: 19221912
Drug: Motivational interviewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational interviewing with a novice therapist in addition to treatment as usual (n=22)
Trial: 19221912
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual alone (n=25)
Trial: 1764954
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 micrograms once-daily
Trial: 1764954
Drug: Budesonide 200
RxNorm normalized name: budesonide 200 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 200 micrograms twice-daily
Trial: 6859504
Drug: 2% lignocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% lignocaine + morphine sulphate 4 mg
Trial: 6859504
Drug: normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: normal saline + morphine sulphate 4 mg
Trial: 27591991
Drug: Olanzapine 10
RxNorm normalized name: olanzapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10 mg/day from day 1 for five consecutive days
Trial: 27591991
Drug: Palonosetron and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron and dexamethasone in approved therapeutic dose from day 1 of chemotherapy
Trial: 22649526
Drug: Guided internet-delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided internet-delivered cognitive behavior therapy (ICBT)
Trial: 19687128
Drug: standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: standard treatment plus applied behavioral analysis (N=32)
Trial: 19687128
Drug: standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: standard treatment only (N=31)
Trial: 17300303
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml of 20% human albumin solution administered over 120 seconds
Trial: 17300303
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of furosemide intravenously along with albumin
Trial: 15067419
Drug: All solutions
RxNorm normalized name: ALCOHOL 0.57 mL in 1 mL / IODINE 0.06 g in 1 mL / POTASSIUM IODIDE 0.05 g in 1 mL / BORIC ACID 0.01 g in 1 mL / SODIUM BORATE 0.002 g in 1 mL TOPICAL LINIMENT [Ball Solutions]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All solutions tested
Trial: 11199951
Drug: Naltrexone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone with cognitive behavioral therapy
Trial: 9894384
Drug: Conventional beta-blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional beta-blockers
Trial: 2806133
Drug: Injection Sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection Sclerotherapy
Trial: 30741103
Drug: modified Story
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modified Story Memory Technique (mSMT) training, twice per week for 5 weeks
Trial: 31289068
Drug: Amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanic acid suspension (intervention)
Trial: 31289068
Drug: Intravenous therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous therapy for another 5 days (control)
Trial: 15635998
Drug: Standard chest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chest physical therapy (CPT)
Trial: 8353361
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 16.5 g of fish oil in 1500 ml (Impact)
Trial: 31010445
Drug: Vortioxetine (flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vortioxetine (flexible doses of 10/20 mg)
Trial: 31010445
Drug: Escitalopram (flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (flexible doses of 10/20 mg)
Trial: 2669154
Drug: 2 gm
RxNorm normalized name: Algiderm 2 gm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 gm of intravenous cefotetan after forceps delivery
Trial: 30138014
Drug: Individual cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual cognitive-behavioral therapy (ICBT)
Trial: 30138014
Drug: Group cognitive-behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive-behavioral therapy (GCBT) for children diagnosed with social anxiety disorder (SOC)
Trial: 26888149
Drug: Higher-dose edoxaban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose edoxaban (60 mg)
Trial: 26888149
Drug: Lower-dose edoxaban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower-dose edoxaban (30 mg)
Trial: 21585523
Drug: Naftazone (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naftazone (titrated up to 120 mg/day)
Trial: 21067351
Drug: Inactivated trivalent
RxNorm normalized name: influenza virus vaccine, inactivated trivalent intradermal suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated trivalent seasonal influenza vaccine (TIV)
Trial: 14962151
Drug: Tramadol 37.5
RxNorm normalized name: ACETAMINOPHEN 325MG/TRAMADOL 37.5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 37.5 mg/acetaminophen 325 mg combination tablets (tramadol/APAP)
Trial: 8130041
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% 1 ml kg-1 + Clonidine 2 micrograms kg-1 in normal saline 1 ml (Group B)
Trial: 8130041
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% 1 ml kg-1 + Normal saline 1 ml (Group A)
Trial: 1104655
Drug: Live, attenuated,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live, attenuated, influenza type A (H3N2) vaccine (Alice)
Trial: 30064455
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid together with 10 × 106 cultured autologous bone marrow-derived MSCs (Low-dose)
Trial: 30064455
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid together with 100 × 106 cultured autologous bone marrow-derived MSCs (High-dose)
Trial: 28801071
Drug: No Treatment
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Treatment (REST)
Trial: 18469276
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with oat and wheat bread and potato (high postprandial insulin response)
Trial: 18469276
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with rye bread and pasta (low postprandial insulin response)
Trial: 16563975
Drug: everolimus 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: everolimus 1.5 mg twice daily (n = 101)
Trial: 16563975
Drug: azathioprine 1
RxNorm normalized name: azathioprine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: azathioprine 1 to 3 mg/kg/day (n = 112)
Trial: 10349694
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with ribavirin and rIFN-alpha 2b
Trial: 7717480
Drug: Midazolam 0.1
RxNorm normalized name: midazolam 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.1 mg.kg‐1 by intramuscular injection as premedication
Trial: 2149533
Drug: Piroxicam 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 1% cream (38 patients)
Trial: 12620603
Drug: Naloxone (opioid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (opioid antagonist)
Trial: 9124664
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow at levels of 0.2-3 l.min-1
Trial: 7957519
Drug: i.v. iopromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. iopromide 15 g iodine
Trial: 7957519
Drug: i.v. iopromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. iopromide 80 g iodine
Trial: 25439040
Drug: Allopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopathic treatment (usually paracetamol, 33.5%) and homeopathic treatment (Oscillococcinum, 56.6%)
Trial: 25439040
Drug: Allopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopathic treatment
Trial: 20018316
Drug: Escalating voltage
RxNorm normalized name: Voltarene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escalating voltage treatment strategy (500 shocks at 14k V, 1,000 at 16 kV, and 1,000 at 18 kV)
Trial: 20018316
Drug: Fixed voltage
RxNorm normalized name: Voltarene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed voltage treatment strategy (2,500 shocks at 18 kV)
Trial: 20018316
Drug: Escalating voltage
RxNorm normalized name: Voltarene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escalating voltage treatment strategy
Trial: 20018316
Drug: Fixed voltage
RxNorm normalized name: Voltarene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed voltage treatment strategy
Trial: 16864174
Drug: Anthracycline containing
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anthracycline containing chemotherapy
Trial: 9661609
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) at an initial dose of 50 mg daily for 5 days, increased to 100 and 150 mg daily in subsequent cycles if no response was observed.
Trial: 3743795
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) treatment
Trial: 7655768
Drug: Maxil (Hikma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxil (Hikma Pharmaceuticals, 750 mg)
Trial: 7655768
Drug: Zinacef (Glaxo,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinacef (Glaxo, 750 mg)
Trial: 2667318
Drug: Mixed-beam therapy
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed-beam therapy
Trial: 766895
Drug: Insulin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (1 unit given intravenously)
Trial: 7016781
Drug: BAY g
RxNorm normalized name: ALCOHOL 70 L in 100 L TOPICAL GEL [Victoria Bay Gel Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY g 5421 (100 mg three times per day)
Trial: 25666740
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 µg)
Trial: 25666740
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin (10 IU)
Trial: 19626807
Drug: Chlorhexidine for
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 2 mg in 1 mL / KETOCONAZOLE 2 mg in 1 mL AURICULAR (OTIC) SOLUTION [Truseb Chlorhexidine for dogs, cats and Horses]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine for skin preparation (group 2)
Trial: 19626807
Drug: Povidone Iodine
RxNorm normalized name: POVIDONE IODINE
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone Iodine for skin preparation (group 1)
Trial: 17312207
Drug: bupivacaine 3
RxNorm normalized name: BUPivacaine 300 MG / meloxicam 9 MG in 10.5 ML Extended Release Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 3 mg + fentanyl 20 mug
Trial: 17312207
Drug: bupivacaine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 7.5 mg
Trial: 17312207
Drug: bupivacaine 5
RxNorm normalized name: Sure-Amp BUPivacaine 5 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 5 mg + fentanyl 20 mug
Trial: 17312207
Drug: bupivacaine 4
RxNorm normalized name: BUPIVACAINE 400MG/MELOXICAM 12MG/VIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 4 mg + fentanyl 20 mug
Trial: 12479490
Drug: Quality improvement
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quality improvement intervention for depression treatment
Trial: 15468432
Drug: Intramuscular ISG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular ISG (4 mL every 2 months from unscreened donors)
Trial: 7656524
Drug: Air as
RxNorm normalized name: OCTINOXATE 2010 mg in 30 mL / OCTOCRYLENE 900 mg in 30 mL / TITANIUM DIOXIDE 600 mg in 30 mL TOPICAL EMULSION [SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT 125 Fair Asterid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air as an insufflation agent
Trial: 7656524
Drug: CO2 as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2 as an insufflation agent
Trial: 2523493
Drug: Ceftriaxone (CTRX)
DrugBank: Ceftriaxone (DB01212)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (CTRX) 1 g once daily
Trial: 2523493
Drug: Cefotiam (CTM)
RxNorm normalized name: cefotiam
DrugBank: Cefotiam (DB00229)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotiam (CTM) 2 g twice daily
Trial: 28569122
Drug: Fingolimod combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod combined with bridging therapy (Alteplase and Mechanical Thrombectomy)
Trial: 28569122
Drug: Bridging therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bridging therapy (Alteplase and Mechanical Thrombectomy) alone